13F Filings History of Cohanzick Management, LLC

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • Cohanzick Management, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • Cohanzick Management, LLC reported 3 equity holdings with a total reported market value of $231,081 for Q1 2024.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
David K. Sherman - Managing Member
Manager location
Pleasantville, NY

Follow Filing Activity

Follow Cohanzick Management, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q1 2024
Latest value
$231,081
Quarter delta
+$231,081
Accepted
14 May 2024, 10:13
Rows shown
1-19 of 19
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q2 2025 0 $0 $0 $0 $0 13F-HR 13 Aug 2025, 09:26
Q1 2025 0 $0 $0 $0 $0 13F-HR 14 May 2025, 10:11
Q4 2024 0 $0 $0 $0 $0 13F-HR 14 Feb 2025, 13:47
Q3 2024 0 $0 $0 $0 $0 13F-HR 13 Nov 2024, 10:50
Q2 2024 0 $0 $0 -$231,081 -$231,081 13F-HR 13 Aug 2024, 09:33
Q1 2024 3 $231,081 +$43,420 -$159,277,899 -$159,234,479 SLND, TALO 13F-HR 14 May 2024, 10:13
Q4 2023 57 $159,278,169 +$112,179,965 -$65,333,289 +$46,846,676 DOCUSIGN INC 0 1/15/2024, JAZZ INVESTMENTS I LTD 1.5 8/15/2024, CTO, ALTERYX INC 0.5 8/1/2024, FOSLL 13F-HR 13 Feb 2024, 10:14
Q3 2023 48 $115,455,769 +$71,762,665 -$38,982,260 +$32,780,405 PARATEK PHARMACEUTICALS 4.75 5/1/2024, NFYS, HYAC, CTO, SCRM 13F-HR 14 Nov 2023, 10:10
Q2 2023 59 $83,360,945 +$34,677,300 -$75,959,096 -$41,281,796 CTO, SPAX, SCRM, ISRL, MBSC 13F-HR 14 Aug 2023, 13:02
Q1 2023 98 $125,200,731 +$70,193,924 -$292,070,189 -$221,876,265 NEW RELIC INC 0.5 5/1/2023, LIGAND PHARMACEUTICALS I 0.75 5/15/2023, CTO, VSAC, SCRM 13F-HR 12 May 2023, 15:00
Q4 2022 198 $345,653,847 +$133,558,501 -$203,465,756 -$69,907,255 ZENDESK INC 0.625 6/15/2025, MIT, ICNC, ENDI, CPTK 13F-HR 13 Feb 2023, 15:00
Q3 2022 289 $412,056,000 +$159,635,367 -$104,042,641 +$55,592,726 MIT, ICNC, CTAQ, EPWR, CPTK 13F-HR 10 Nov 2022, 14:09
Q2 2022 383 $353,750,000 +$131,611,681 -$218,209,077 -$86,597,396 MIT, CC NEUBERGER PRINCIPAL-CL A, CTAQ, ICNC, BGPPF 13F-HR 12 Aug 2022, 10:51
Q1 2022 427 $441,974,000 +$181,473,864 -$303,430,108 -$121,956,244 ZNTE, MIT, LNFA, CTAQ, ICNC 13F-HR 13 May 2022, 10:40
Q4 2021 408 $563,897,543 +$369,495,852 -$221,221,582 +$148,274,270 GOLAR LNG LTD 2.75 2/15/2022, CHENIERE ENERGY INC 4.25 3/15/2045, ZNTE, MIT, DISH NETWORK CORP 2.375 3/15/2024 13F-HR 14 Feb 2022, 08:06
Q3 2021 222 $414,266,000 +$174,555,750 -$74,431,615 +$100,124,135 ENFA, MIT, DISH NETWORK CORP 2.375 3/15/2024, THMA, LOKB 13F-HR 12 Nov 2021, 13:11
Q2 2021 169 $315,294,000 +$229,749,737 -$76,575,790 +$153,173,947 MIT, LOKB, THMA, ROT, VAQC 13F-HR 13 Aug 2021, 14:43
Q1 2021 109 $161,349,000 +$139,467,733 -$103,811,973 +$35,655,760 MITU, VAQC, OCA, ASAQ, CTAQ 13F-HR 14 May 2021, 09:35
Q4 2020 68 $126,242,000 $0 $0 $0 ACICU, RMGBU, TWND, OCAU, TSIAU 13F-HR 12 Feb 2021, 16:01
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .